SCHEMBL780333

SCHEMBL780333

N#CCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2648857 0.77
SCHEMBL3976313 0.74
SCHEMBL8882387 0.72
SCHEMBL8654779 0.72
SCHEMBL16037462 0.71 ALDH1A1 (1.00)
SCHEMBL56391 0.71
Lithium SCHEMBL29833770 0.67
SCHEMBL2683512 0.67
SCHEMBL30321467 0.67
Lithium SCHEMBL29763173 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290398-A Water-soluble copper ion fluorescent probe based on hemicyanine and preparation and application thereof 贺州学院 2024-07-05 CN claimed
CN-118255744-A Water-soluble copper ion colorimetric fluorescent probe based on hemicyanine and preparation and application thereof 贺州学院 2024-06-28 CN claimed
CN-115141104-A Environment-friendly organic amine and preparation method and application thereof 万华化学集团股份有限公司 2022-10-04 CN claimed
EP-3643704-B1 NEW INTERMEDIATES FOR THE PREPARATION OF REMIFENTANIL HYDROCHLORIDE HAMELN PHARMA GMBH (DE) 2020-12-16 EP claimed
US-10844014-B2 Intermediates for the preparation of remifentanil hydrochloride HAMELN PHARMA GMBH (DE) 2020-11-24 US claimed
US-20200131127-A1 INTERMEDIATES FOR THE PREPARATION OF REMIFENTANIL HYDROCHLORIDE HAMELN PHARMA PLUS GMBH (DE) 2020-04-30 US claimed
EP-3643704-A1 NEW INTERMEDIATES FOR THE PREPARATION OF REMIFENTANIL HYDROCHLORIDE hameln pharma plus gmbh (DE) 2020-04-29 EP claimed
CN-107255635-B The polybutadiene alkynes probe test paper of imidazoles functionalization and the method for detecting ovarian cancer markers' concentration with foregoing probes 中国科学院长春应用化学研究所 2019-10-18 CN claimed
CN-106565503-B The method for synthesizing (1R, 2S) -1- amino-(3,4- difluorophenyls)-cyclopropane 华北理工大学 2018-04-24 CN claimed
EP-4746963-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-27 EP disclosed
CN-122036604-A Compound and application thereof 中国药科大学 2026-05-15 CN disclosed
EP-3587432-B1 NUCLEIC ACID COMPOUND AND OLIGONUCLEOTIDE UNIV OSAKA (JP) 2026-05-06 EP disclosed
WO-2025017045-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2025-01-23 WO disclosed
CN-118290398-A Water-soluble copper ion fluorescent probe based on hemicyanine and preparation and application thereof 贺州学院 2024-07-05 CN disclosed
WO-2005087730-A1 3,4-(CYCLOPENTYL)-FUSED PROLINE COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-09-22 WO disclosed
WO-2005087721-A2 COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-09-22 WO disclosed
WO-2005087725-A2 NOVEL COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-09-22 WO disclosed
WO-2005085242-A1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2005-09-15 WO disclosed
US-5384396-A Process for the deoxygenation of nucleosides THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1995-01-24 US disclosed
WO-1992015598-A1 PROCESS FOR THE DEOXYGENATION OF NUCLEOSIDES UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1992-09-17 WO disclosed